INNV has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
INNV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, InnovAge Holding's Enterprise Value is $559.3 Mil. InnovAge Holding's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-29.5 Mil. Therefore, InnovAge Holding's EV-to-EBIT ratio for today is -18.99.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, InnovAge Holding's Enterprise Value is $559.3 Mil. InnovAge Holding's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was $-11.5 Mil. Therefore, InnovAge Holding's EV-to-EBITDA ratio for today is -48.64.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, InnovAge Holding's Enterprise Value is $559.3 Mil. InnovAge Holding's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $741.3 Mil. Therefore, InnovAge Holding's EV-to-Revenue ratio for today is 0.75.
The historical data trend for InnovAge Holding's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InnovAge Holding Annual Data | |||||||||||
Trend | Jun19 | Jun20 | Jun21 | Jun22 | Jun23 | ||||||
Enterprise Value | - | - | 2,792.44 | 515.40 | 971.17 |
InnovAge Holding Quarterly Data | |||||||||||||||||||
Jun19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Enterprise Value | Get a 7-Day Free Trial | 1,045.19 | 971.17 | 802.68 | 846.51 | 633.28 |
For the Medical Care Facilities subindustry, InnovAge Holding's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, InnovAge Holding's Enterprise Value distribution charts can be found below:
* The bar in red indicates where InnovAge Holding's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
InnovAge Holding's Enterprise Value for the fiscal year that ended in Jun. 2023 is calculated as
Enterprise Value (A: Jun. 2023 ) | |||||
= | Market Cap | + | Preferred Stock | + | Long-Term Debt & Capital Lease Obligation |
= | 1017.3 | + | 0 | + | 96.786 |
+ | Short-Term Debt & Capital Lease Obligation | + | Minority Interest | - | Cash, Cash Equivalents, Marketable Securities |
+ | 12.047 | + | 18.501 | - | 173.462 |
= | 971.2 |
InnovAge Holding's Enterprise Value for the quarter that ended in Mar. 2024 is calculated as
Enterprise Value (Q: Mar. 2024 ) | |||||
= | Market Cap | + | Preferred Stock | + | Long-Term Debt & Capital Lease Obligation |
= | 603.507 | + | 0 | + | 99.541 |
+ | Short-Term Debt & Capital Lease Obligation | + | Minority Interest | - | Cash, Cash Equivalents, Marketable Securities |
+ | 12.389 | + | 17.172 | - | 99.33 |
= | 633.3 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InnovAge Holding (NAS:INNV) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
InnovAge Holding's EV-to-EBIT for today is
EV-to-EBIT | = | Enterprise Value (Today) | / | EBIT (TTM) |
= | 559.270 | / | -29.452 | |
= | -18.99 |
InnovAge Holding's current Enterprise Value is $559.3 Mil.
InnovAge Holding's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-29.5 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
InnovAge Holding's EV-to-EBITDA for today is:
EV-to-EBITDA | = | Enterprise Value (Today) | / | EBITDA(TTM) |
= | 559.270 | / | -11.499 | |
= | -48.64 |
InnovAge Holding's current Enterprise Value is $559.3 Mil.
InnovAge Holding's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-11.5 Mil.
3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.
InnovAge Holding's EV-to-Revenue for today is:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | 559.270 | / | 741.328 | |
= | 0.75 |
InnovAge Holding's current Enterprise Value is $559.3 Mil.
InnovAge Holding's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $741.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of InnovAge Holding's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Teresa Sparks | director | 40 BURTON HILLS BOULEVARD SUITE 500, NASHVILLE TN 37215 |
Nicole Damato | officer: CHIEF LEGAL OFFICER | 8950 E. LOWRY BOULEVARD, DENVER CO 80230 |
Benjamin C Adams | officer: CHIEF FINANCIAL OFFICER | 8950 E. LOWRY BOULEVARD, DENVER CO 80230 |
Patricia Fontneau | director | 8950 E. LOWRY BOULEVARD, DENVER CO 80230 |
Christine Bent | officer: CHIEF OPERATIONS OFFICER | 8950 E. LOWRY BOULEVARD, DENVER CO 80230 |
Thomas Scully | director | 320 PARK AVENUE, SUITE # 2500, NEW YORK NM 10022 |
Richard Feifer | officer: CHIEF MEDICAL OFFICER | C/O GENESIS HEALTHCARE, INC., 101 EAST STATE STREET, KENNETT SQUARE PA 19348 |
James G Carlson | director | 8950 E. LOWRY BOULEVARD, DENVER CO 80230 |
Patrick T Blair | officer: PRESIDENT | 8950 E. LOWRY BOULEVARD, DENVER CO 80230 |
Caroline Dechert | director | 580 CALIFORNIA ST., SUITE 1700, SAN FRANCISCO CA 94104 |
Pavithra Mahesh | director | 601 LEXINGTON AVE., 53RD FLOOR, NEW YORK NY 10022 |
Maureen Hewitt | director, officer: CEO, President and Director | 8950 E. LOWRY BLVD., DENVER CO 80230 |
Maria Lozzano | officer: CORPORATE COO | 8950 E. LOWRY BLVD., DENVER CO 80230 |
Robin Doerr | officer: CHIEF SALES AND MKTG. OFFICER | 8950 E. LOWRY BLVD., DENVER CO 80230 |
Melissa Welch | officer: CHIEF MEDICAL OFFICER | 8950 E. LOWRY BLVD., DENVER CO 80230 |
From GuruFocus
By Value_Insider Value_Insider • 10-25-2022
By PRNewswire PRNewswire • 07-03-2022
By PRNewswire PRNewswire • 06-30-2022
By sperokesalga sperokesalga • 05-01-2023
By PRNewswire PRNewswire • 06-10-2022
By sperokesalga sperokesalga • 06-05-2023
By sperokesalga sperokesalga • 04-25-2023
By PRNewswire PRNewswire • 06-03-2022
By sperokesalga sperokesalga • 03-30-2023
By Stock market mentor Stock market mentor • 01-05-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.